ANXIETY-DEPRESSIVE SPECTRUM DISORDERS IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION IN THE LONG TERM AFTER SURGERY

Highlights

• The article presents the analysis of anxiety and depressive disorders in patients who were followed as outpatients after surgery for chronic thromboembolic pulmonary hypertension in the long term, taking into account the study during the COVID–19 pandemic.
• The prevalence of clinically pronounced anxiety disorders in the group was 10.9%, depression - 18.6%, a combination of anxiety-depressive disorders was noted in 10.3% of cases.
• Multifactorial analysis revealed that the development of severe anxiety disorders in patients with chronic thromboembolic pulmonary hypertension in the long term is associated with a complicated postoperative course. Independent risk factors for clinically pronounced depressive disorders in these patients were older age, a history of cerebral circulation disorders, as well as pronounced post-COVID-19 functional disorders.

Aim. To study the frequency and severity of anxiety-depressive disorders in patients with chronic thromboembolic pulmonary hypertension (CTEPH) in the long term after pulmonary thromboendarterectomy and to identify factors affecting their development.

Methods. 156 patients with CTEPH were examined in the long term after surgery using the generalized anxiety disorder (GAD) questionnaire GAD-7 and the Beck`s Depression Inventory. In patients who suffered COVID-19, a “Post-COVID-19 Functional Status scale” (PCFS) was used to measure functional status over time after COVID-19. Logistic regression analysis was used to identify predictors of clinically pronounced GAD and depression in the long-term period after surgery.

Results. In patients with CTEPH, clinically significant GAD and depression in the long term after surgery were observed in 10.9 and 18.6% of cases, respectively. A combination of anxiety and depressive disorders was noted in 10.3% of patients. The development of GAD was associated with cardiopulmonary insufficiency in the early postoperative period (ОR 3,1; CI 1,2–13,8; p = 0,009). Clinically pronounced depression was associated with older age (ОR 1,3; CI 1,04–2,0; p = 0,02), chronic cerebral circulatory insufficiency (ОR 7,6; CI 1,8–17,5; p = 0,02) and pronounced post-COVID-19 functional neurological disorders according to the PCFS scale (ОR 6,7; CI 1,9–14,5; p = 0,007). The combination of clinically expressed anxiety and depression was correlated with older age (ОR 1,1; CI 1,02–1,3; p = 0,04).

Conclusion. The prevalence of clinically pronounced GAD in the group was 10.9%, depression was 18.6%, and a combination of anxiety and depressive disorders was noted in 10.3% of patients. The development of clinically significant GAD is associated with a complicated course of cardiac surgery. Independent risk factors for clinically significant depression were older age, a history of cerebral circulatory disorders and pronounced post-COVID-19 functional neurological disorders.

1. REFERENCES

2. Hernández-Palazón J., Fuentes-García D., Falcón-Araña L., Roca-Calvo M.J., Burguillos-López S., Doménech-Asensi P., Jara-Rubio R. Assessment of Preoperative Anxiety in Cardiac Surgery Patients Lacking a History of Anxiety: Contributing Factors and Postoperative Morbidity. Journal of Cardiothoracic and Vascular Anesthesia. 2018; 32 (1): 236-44. doi:10.1053/j.jvca.2017.04.044

3. Younes O., Amer R., Fawzy H., Shama G. Psychiatric disturbances in patients undergoing open-heart surgery. Middle East Curr Psychiatry. 2019; 26. doi:10.1186/s43045-019-0004-9

4. Zhou X., Shi H., Yang Y., Zhang Z., Zhai Z., Wang C. Anxiety and depression in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a Chinese survey. Experimental and Therapeutic Medicine. 2020; doi:10.3892/etm.2020.8566

5. Kamenskaya O., Klinkova A., Chernyavskiy A., Lomivorotov V.V., Edemskiy A., Shmyrev V. Long-term health-related quality of life after surgery in patients with chronic thromboembolic pulmonary hypertension. Quality of Life Research. 2020; 29 (8): 2111–8. doi:10.1007/s11136-020-02471-z

6. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry. 1961; 4 (6): 561-571.

7. http://www.psycabi.net/testy/592-shkala-test-oprosnik-depressii-beka-kognitivnaya-terapiya-beka-ili-kak-vyjti-iz-depressiiэлектронный ресурс

8. Spitzer R.L., Kroenke K., Williams J.B.W., Löwe B. A brief measure for assessing generalized anxiety disorder the GAD-7. Arch. Intern. Med. 2006; 166 (10): 1092–1097. doi: 10.1001/archinte.166.10.1092

9. COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (NICE). 2020. PMID: 33555768.

10. Klok F.A., Boon G.J.A.M., Barco S., Endres M., Geelhoed J.J.M., Knauss S., Rezek S.A.,. Spruit M.A., Vehreschild J., Siegerink B. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. European Respiratory Journal. 2020; 56 (1): 2001494. doi:10.1183/13993003.01494-2020

11. Belotserkovskaya YuG, Romanovskikh AG, Smirnov IP, Sinopalnikov AI. Long COVID-19. Consilium Medicum. 2021; 23 (3): 261–268. (In Russian) doi: 10.26442/20751753.2021.3.200805

12. Ostroumova O.D., Goloborodova I.V., Fomina V.M., Bondarets O.V. Anxiety and depressive disorders in cardiology practice. Possibilities of using D, L-gopantenic acid. Consilium Medicum. 2018; 20 (12): (In Russian) doi: 10.26442/20751753.2018.12.000032

13. Petrova N.N., Kovaltsova R.S., Dorofeykov V.V., Mashek O.N., Bautin A.E., Tashkhanov D.M. Mental disorders, psychological characteristics and markers of central nervous system damage in patients undergoing cardiac surgery with extracorporeal circulation. Neurology Bulletin. 2016; XLVIII (3): 18-24. (In Russian) doi: 10.17816/nb13993

14. Soloduhin A.V., Trubnikova O.A., Yanickij M.S., Seryj A.V., Barbarash O.L. Clinical-psychological characteristics of patients with CHD before preparation for coronary bypass depending on their psycho-emotional status. Lechashchij vrach. 2017; 11: 76-79. (In Russian) EDN ZSVJAB

15. Callus E., Pagliuca S., Bertoldo E.G., Fiolo V., Jackson A.C., Boveri S., De Vincentiis C., Castelvecchio S., Volpe M and Menicanti L. The Monitoring of Psychosocial Factors During Hospitalization Before and After Cardiac Surgery Until Discharge From Cardiac Rehabilitation: A Research Protocol. Front. Psychol. 2020; 11: 2202. doi: 10.3389/fpsyg.2020.02202

16. [Petrova N.N., Savickaya K.S. The diagnosis and therapy of comorbid anxiety and depression disorders in clinical practice. V.M. Bekhterev review of psychiatry and medical psychology. 2021; 1: 102-112. (In Russian) doi:10.31363/2313-7053-2021-1-102-112

17. Khramov E.V., Ivanov V.S. Modern foreign studies of depressive disorders during the COVID-19 pandemic. Sovremennaya zarubezhnaya psikhologiya = Journal of Modern Foreign Psychology. 2021; 10 (1): 39-47. (In Russian) doi:10.17759/jmfp.2021100104

18. Tang M., Wang S-H., Li H-L., Chen H., Sun X-Y., Bian W-W., Sheng J., Ma S.-J. Mental health status and quality of life in elderly patients with coronary heart disease. PeerJ. 2021; 9:e10903. doi:10.7717/peerj.10903

19. Bogolepova A.N. Vascular depression and cognitive dysfunction. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019; 11 (3): 26-31. (In Russian) doi:10.14412/2074-2711-2019-3S-26-31

20. Shuteeva TV. Modern approaches to the correction of cognitive and emotional disorders in patients with chronic cerebral ischemia. Russian Medical Journal. 2017;21: 1507-1510. (In Russian)

21. Abritalin EY. About the causes and therapy of depressive disorders in COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2021; 121 (8): 87-92. (In Russian) doi:10.17116/jnevro202112108187

22. Carod-Artal F.J. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev Neurol. 2021; 72 (11): 384-396. English, Spanish. doi:10.33588/rn.7211.2021230

23. Helms J., Kremer S., Merdji H., Clere-Jehl R., Schenck M., Kummerlen C., Collange O., Boulay C., Fafi-Kremer S., Ohana M., Anheim M., Meziani F. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med. 2020; 382: 2268-2270. doi:10.1056/NEJMc2008597

24. Mosolov S.N. Long-term psychiatric sequelae of SARS-CoV-2 infection. Sovrem. ter. psih. rasstrojstv. 2021; 3: 2-23. (In Russian) doi:10.21265/PSYPH.2021.31.25.001